Article Sidebar

PDF
Date Published: 13/09/2021
Abstract Views: 547
Views PDF: 280
DOI: https://doi.org/10.51298/vmj.v505i2.1095
Issue
Vol. 505 No. 2 (2021)
Section
Các bài báo
How to Cite
Lê Huy, T. ., & Việt, L. . (2021). EVALUATION THE ACCURACY OF TRANSRECTAL ULTRASOUND GUIDED BIOPSY IN DIAGNOSING PROSTATE CANCER. Vietnam Medical Journal, 505(2). https://doi.org/10.51298/vmj.v505i2.1095

EVALUATION THE ACCURACY OF TRANSRECTAL ULTRASOUND GUIDED BIOPSY IN DIAGNOSING PROSTATE CANCER

Trịnh Lê Huy1,, Lê Việt2
1 Hanoi Medical University
2 K Hospital

Main Article Content

Abstract

Study of 84 patients undergone transrectal ultrasound guided prostate at radiology department of National Cancer Hospital between December 2017 and June 2020.Mean age was 72.1. The main presenting reasonsymptomwas urinary retention (92.8%). 22.6% of all patients required catheterisation (an indwelling urethral catheter or a suprapubic catheter). The rate of suspicious symptoms of prostate cancer diagnosed by clinical examination, abdominal ultrasound and transrectal ultrasound were 44%, 27.3% and 41.6%, respectively. Most patients had 10 samples (73.8%). Sensitivity and specificity were 93.8% and 82.8%, respectively. The positive predicted value and negative predicted value were 88.4% and 90.6%, respectively. After biopsy, 17,8% of all patients had rectal bleeding, followed by hematuria (14.2%); one patient got perineal inflammation. All of these complications were mild and recoveredsoon after procedure.To sum up, Transrectal ultrasound guided biopsy in diagnosing prostate cancer was safe and had high accuracy.

Article Details

Keywords

Prostate cancer, Transrectal ultrasound guided biopsy

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
2. Bruyerre.F, O. Traxer (2005), “Prise en charge du cancer de la prostate”. Annales d’Urologie. ( Vol 39/suppl.1, Pg 1-16).
3. J.Stephen Jone, MD (2008), "Definin the problem: From subclinical disease to clinically insignifcant prostate cancer”. Prostate byopsy. Chapter 1, pp 16 -17.
4. Lê Ngọc Bằng (2005), “Vai trò của sinh thiết kết hợp với PSA và siêu âm trong chẩn đoán UTTTL” Đề tài thạc sĩ y học ngoại khoa.
5. Khoury.S (1998), “Les stades du cancer de la prostate” (Pg167), “ Diagnostic du cancer de la prostate”(Pg179). Urologie – Cancer de la prostate.
6. Joe Philip, Subhajit Dutta Joy and al (2005), “Is a Digital Rectal Examination Necessary in the Diagnosis and Clinical Staging of Early Prostate Cancer”, BJU International, 95, Pg 969-971.
7. Terris M.K (1999), “Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report”.Urology. Sep;54(3):486-9.
8. Epstein JI, Sanderson H, Carter HB, Schafstein DO (2005).“Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy”. Urology. Aug; 66(2):356-60.